The overall survival was longer in COAD patients when levels of CXCL8/11/14 expression were higher (P ≤ 0.05) (Figures 4(a)–4(c)) or when levels of VEGFA expression were lower (P < 0.05) (Figure 4(d)). This evidence concerns the gene CXCL8 and colon adenocarcinoma.